Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ranja Gupta"'
Autor:
Elaine M Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S Ross, Pedram Razavi, Shanu Modi, Neil M Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsky, Jackie Bromberg, Pamela Drullinsky, Diana Lake, Serena Wong, Patricia DeFusco, Nicholas Lamparella, Ranja Gupta, Tasmila Tabassum, Leigh Ann Boyle, Artavazd Arumov, Tiffany A Traina
Publikováno v:
Cancer Research. 82:P1-14
Background: Chemotherapy remains the mainstay of treatment for early-stage triple negative breast cancer (TNBC), yet targetable drivers of interest are under investigation. A subset of TNBCs express the androgen receptor (AR) and exhibit androgen-dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c13cb51455eb77d7eedf06d84d46453
https://doi.org/10.1158/1538-7445.sabcs21-p1-14-03
https://doi.org/10.1158/1538-7445.sabcs21-p1-14-03
Autor:
Elaine M. Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S. Ross, Pedram Razavi, Shanu Modi, Neil M. Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsky, Jacqueline Bromberg, Pamela Drullinsky, Diana Lake, Serena Wong, Patricia Ann DeFusco, Nicholas Lamparella, Ranja Gupta, Tasmila Tabassum, Leigh Ann Boyle, Artavazd Arumov, Tiffany A. Traina
Publikováno v:
Breast cancer research and treatment. 195(3)
Chemotherapy with or without immunotherapy remains the mainstay of treatment for triple-negative breast cancer (TNBC). A subset of TNBCs express the androgen receptor (AR), representing a potential new therapeutic target. This study assessed the feas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2e3c8d641ff0c1453658b5161f94ac
https://pubmed.ncbi.nlm.nih.gov/35986801
https://pubmed.ncbi.nlm.nih.gov/35986801